These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15664243)

  • 1. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.
    Ahn SH; Park YN; Park JY; Chang HY; Lee JM; Shin JE; Han KH; Park C; Moon YM; Chon CY
    J Hepatol; 2005 Feb; 42(2):188-94. PubMed ID: 15664243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.
    Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Wang LY; You SL; Iloeje UH; Chen CJ;
    Gastroenterology; 2010 Aug; 139(2):474-82. PubMed ID: 20434450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
    Yuen MF; Wong DK; Sablon E; Tse E; Ng IO; Yuan HJ; Siu CW; Sander TJ; Bourne EJ; Hall JG; Condreay LD; Lai CL
    Hepatology; 2004 Jun; 39(6):1694-701. PubMed ID: 15185311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma.
    Liu J; Yang HI; Lee MH; Lu SN; Jen CL; Batrla-Utermann R; Wang LY; You SL; Hsiao CK; Chen PJ; Chen CJ;
    Gut; 2014 Oct; 63(10):1648-57. PubMed ID: 24225939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients.
    Chan HL; Wong GL; Tse CH; Chan HY; Wong VW
    J Infect Dis; 2011 Aug; 204(3):408-14. PubMed ID: 21742839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance.
    Arai M; Togo S; Kanda T; Fujiwara K; Imazeki F; Yokosuka O
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):414-8. PubMed ID: 22273987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
    Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
    J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B surface antigen seroclearance during chronic HBV infection.
    Chu CM; Liaw YF
    Antivir Ther; 2010; 15(2):133-43. PubMed ID: 20386068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver histopathological features of chronic HBV carriers and inactive HBsAg carriers].
    Fan HM; Yang Z; Zhang CL; Li WL
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):334-7. PubMed ID: 17524263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
    Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M
    Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term histologic and virologic outcomes of acute self-limited hepatitis B.
    Yuki N; Nagaoka T; Yamashiro M; Mochizuki K; Kaneko A; Yamamoto K; Omura M; Hikiji K; Kato M
    Hepatology; 2003 May; 37(5):1172-9. PubMed ID: 12717399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
    Gigi E; Lalla T; Orphanou E; Sinakos E; Vrettou E; Raptopoulou-Gigi M
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?
    Chu CM; Lin DY; Liaw YF
    Int J Obes (Lond); 2007 May; 31(5):871-5. PubMed ID: 17047638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
    Moucari R; Marcellin P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S119-25. PubMed ID: 21095515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
    Koçak N; Ozen H; Yüce A; Gürakan F
    Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.